Histamine dihydrochloride
Ceplene is a twice-daily injection of histamine given alongside low-dose interleukin-2 as maintenance treatment for adults with acute myeloid leukaemia in first remission, to help immune cells prevent relapse. It is authorised in Europe only.
Overview
Histamine dihydrochloride was authorised in the EU in October 2008 under exceptional circumstances, with low-dose interleukin-2, as maintenance therapy for adults with acute myeloid leukaemia in first complete remission, on a phase 3 trial of 320 patients in which the combination improved leukaemia-free survival compared with no maintenance; the label notes efficacy is not fully established over age 60 and an FDA application was not approvable in 2000. It is one of the very few approved maintenance immunotherapies in AML, though oral azacitidine (Onureg) and FLT3 inhibitors now fill that space, and it is little used. Flushing, headache, hypotension and injection-site reactions occur with each histamine dose.
Approvals
| Region | Year | Indication |
|---|---|---|
| EU | 2008 | Maintenance with interleukin-2 for adults with AML in first remission (exceptional circumstances) |
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Histamine dihydrochloride" OR ABSTRACT:"Histamine dihydrochloride" OR TITLE:"Ceplene" OR ABSTRACT:"Ceplene") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Histamine dihydrochloride, not a curated reading list.
Pages like this
not linked directly; found by shared links- ProductTasonermin
Shares Cytokines & engineered cytokines and the tag ema-list.
- ProductDorocubicel (UM171-expanded cord blood)
Shares Acute myeloid leukaemia and the tag ema-list.
- PersonMichael A. Caligiuri
Shares Cytokines & engineered cytokines, Acute myeloid leukaemia.
- TermCytokine
Shares Aldesleukin (high-dose IL-2), Cytokines & engineered cytokines.
- InstitutionNCI Center for Cancer Research (intramural programme)
Shares Aldesleukin (high-dose IL-2), Cytokines & engineered cytokines.